Back to search

University of British Columbia

Characterization of allele-specific 5-methylcytosine in cancer and quantification of 8-oxoguanine using nanopore sequencing

Abstract

dc:description

5-methylcytosine (5mC) and 8-oxoguanine (8oxoG) are two DNA modifications which each have epigenetic roles and are implicated in disease pathophysiology. 5mC, commonly referred to as DNA methylation, is a heritable epigenetic mark that primarily silences gene expression by disrupting transcription factor binding to regulatory elements. While being a well-characterized mark, methods to detect 5mC such as whole genome bisulfite sequencing and methylation arrays are limited in scope and cannot sufficiently phase 5mC. Phasing of 5mC is necessary to measure allele-specific methylation (ASM) which is the phenomena of asymmetrical methylation profiles across different alleles. Nanopore sequencing is a long-read technology which can generate megabase scale phase blocks of 5mC. This sequencing technology was employed to identify ASM across 207 tumour genomes encompassing a variety of tumour types. Recurrent ASM was found in the context of both tumour suppressor gene (TSG) and oncogene regulation. Notably, intragenic methylation was found to be a potential regulator of cancer gene and isoform expression. In the TSGs BRCA1 and RAD51C, promoter methylation with a double hit of loss of heterozygosity (LoH) was found to result in the clinically relevant homologous recombination deficiency (HRD) phenotype. Breast and ovarian cancers with aberrant methylation were found to be enriched in somatic alterations in gene regulatory regions. A subset of HRD cases, were found to have promoter indels which may be acting as reversion mutations to restore gene functionality and confer treatment resistance. The use of nanopore resulted in an unprecedented scale and resolution to explore the regulatory mechanisms of 5mC in cancer. Reactive oxygen species (ROS) can convert guanine to 8oxoG which is a mutagenic mark that leads to G > T mutations. 8oxoG is prominent in mitochondrial disease as mitochondrial DNA (mtDNA) is particularly susceptible to the intrinsic production of ROS during aerobic respiration. Using nanopore sequencing, a recurrent convolutional neural network was trained to detect 8oxoG in the mitochondrial genome. This model was found to be over 99.9% specific and was able to distinguish samples with mitochondrial disease. Ultimately, this thesis displays the potential of nanopore to quantify and characterize DNA modifications.

Degree

thesis:*
Name thesis:degree_name
Master of Science - MSc
Level thesis:degree_level
master's
Discipline thesis:degree_discipline
Bioinformatics
Grantor dc:publisher
University of British Columbia
Year dc:date
2024

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Galbraith, Andrew Joseph
Contributors dc:contributor
  • Jones, Steven J. M.

Rights

dc:rights
Statement dc:rights
  • Attribution-NonCommercial-NoDerivatives 4.0 International
Language dc:language
eng

Identifiers

dc:identifier.*
Handle dc:identifier
http://hdl.handle.net/2429/88582

Chain of custody

source
Harvested from
University of British Columbia
Base URL
circle.library.ubc.ca/oai/request
Last updated
2026-11-19
Source record
OAI-PMH GetRecord
related terms
citation

Galbraith, Andrew Joseph. Characterization of allele-specific 5-methylcytosine in cancer and quantification of 8-oxoguanine using nanopore sequencing. master's thesis, University of British Columbia, 2024. http://hdl.handle.net/2429/88582